Chongqing Lummy Phar (300006.SZ) traded flat 0 % during a 24 hours period ending at 01:09 AM Central Europe on Tuesday 27th. One Chongqing Lummy Phar stock can currently be bought for about CNY 8.85 on popular exchanges. Current supply of Chongqing Lummy Phar stocks is 1.1 bn. Chongqing Lummy Phar has a current market capitalization of CNY 8.3 bn and approximately CNY 1.7 bn worth of Chongqing Lummy Phar was traded on exchanges in the last 24 hours. Since last month end, Chongqing Lummy Phar has traded 43.49 % up. Simple moving average of last 200 days is at CNY 5.44. The highest price of past 52 weeks was recorded at CNY 9.76 on 10/16/2026. 52 weeks low was at CNY 4.3 on 06/22/2026.

Here is how related stocks have performed in the past 24 hours:

  • Tibet Mineral Development (000762.SZ) traded flat 0 % and now trades at CNY 19.05. Current market capitalisation for Tibet Mineral Development is CNY 9.9 bn. Tibet Mineral Development has a current price to earnings ratio of 210.86.

  • Wondershare Gr (300624.SZ) traded flat 0 % and now trades at CNY 50.03. Wondershare Gr has a market capitalisation of CNY 9.9 bn.

  • Microport Scientific (0853.HK) traded up 0.16 % and now trades at HKD 6.08. Current market capitalisation for Microport Scientific is HKD 11.7 bn.

  • Fujian Expressway Developm (600033.SS) traded flat 0 % and now trades at CNY 3.59. Fujian Expressway Developm has a market capitalisation of CNY 9.9 bn. Current price/earnings ratio for Fujian Expressway Developm is 10.78.

  • Scantech Hangzhou (688583.SS) traded flat 0 % and now trades at CNY 81.5. Current market capitalisation for Scantech Hangzhou is CNY 9.9 bn.

About Chongqing Lummy Phar

Chongqing Lummy Pharmaceutical Co., Ltd. is a health care company operating in the pharmaceutical industry of China. The company, established in 1999 and headquartered in Chongqing, researches, develops, manufactures, and sells a variety of pharmaceutical products. These include tumor, antibacterial, antiviral, and antifungal drugs; liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; acid-base balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients.